|
Three new presentations about the Translumina Yukon DES stent platform were presented on the PCR 2011 in Paris. All presentations were well attended and they showed the versatility of the unique Translumina Stent Coating Technology, that allows for the coating of coronary stents with different coating formulations.
Especially the polymer-free Rapamycin coating showed excellent clinical outcomes in the 5-year follow-up investigation of the ISAR-TEST 1 trial. There were no late or very late stent thrombosis cases in the Yukon DES study arm vs. 2 cases in the competitor cohort.
For the full presentation please get the pdf.
For further info do not hesitate to contact us! |
|